BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8617944)

  • 1. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    Teng JM; Liu XR; Mills GB; Dupont B
    J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
    Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas involvement in cytotoxicity mediated by human NK cells.
    Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z
    Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca(2+)-independent costimulatory activity.
    Lu Y; Phillips CA; Bjorndahl JM; Trevillyan JM
    Eur J Immunol; 1994 Nov; 24(11):2732-9. PubMed ID: 7957566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis.
    Roger R; Bréard J; Comisso M; Bohuon C; Pallardy M; Bertoglio J
    Cell Immunol; 1996 Feb; 168(1):24-32. PubMed ID: 8599836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction in activated natural killer cells and natural killer cells inactivated with sensitive targets.
    Gibboney JJ; Shenoy AM; Jin X; Brahmi Z
    Nat Immun; 1992; 11(2):57-68. PubMed ID: 1498520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones.
    Anel A; Simon AK; Auphan N; Buferne M; Boyer C; Golstein P; Schmitt-Verhulst AM
    Eur J Immunol; 1995 Dec; 25(12):3381-7. PubMed ID: 8566027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinase EMT/ITK/TSK: functional and physical interaction of EMT with phosphatidylinositol 3-kinase.
    Lu Y; Cuevas B; Gibson S; Khan H; LaPushin R; Imboden J; Mills GB
    J Immunol; 1998 Nov; 161(10):5404-12. PubMed ID: 9820515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YT.
    Kos FJ; Bear HD
    Immunology; 1998 Aug; 94(4):575-9. PubMed ID: 9767447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1. Possible involvement of LFA-1-associated tyrosine kinase in signal transduction after recognition of NK target cells.
    Sugie K; Minami Y; Kawakami T; Uchida A
    J Immunol; 1995 Feb; 154(4):1691-8. PubMed ID: 7836753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast cells.
    Kawakami Y; Yao L; Tashiro M; Gibson S; Mills GB; Kawakami T
    J Immunol; 1995 Oct; 155(7):3556-62. PubMed ID: 7561053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
    Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
    Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
    Gold MR; Aebersold R
    J Immunol; 1994 Jan; 152(1):42-50. PubMed ID: 8254204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of function-associated molecules on rat leukemic NK cells: activation by monoclonal antibody or phorbol ester.
    Evans DL; Harris DT; Staton DL; Jaso-Friedmann L
    Nat Immun Cell Growth Regul; 1990; 9(6):353-65. PubMed ID: 2087244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.